|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn868069010 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140114s2012 onc ob 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OCLCQ
|d EBLCP
|d AGLDB
|d MERUC
|d OCLCQ
|d OCLCA
|d OCLCQ
|d STF
|d OCLCQ
|d OCLCO
|d OCLCA
|d VLB
|d VLY
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|
016 |
|
|
|z 20129022411 (print)
|
019 |
|
|
|a 1162394014
|
020 |
|
|
|a 9781442661127
|q (electronic bk.)
|
020 |
|
|
|a 1442661127
|q (electronic bk.)
|
020 |
|
|
|a 1442698276
|
020 |
|
|
|a 9781442698277
|
020 |
|
|
|z 9781442643970
|
020 |
|
|
|z 1442643978
|
029 |
1 |
|
|a DEBBG
|b BV042740417
|
029 |
1 |
|
|a DEBSZ
|b 423719173
|
029 |
1 |
|
|a GBVCP
|b 799462357
|
035 |
|
|
|a (OCoLC)868069010
|z (OCoLC)1162394014
|
050 |
|
4 |
|a HD9665.5
|b .A27 2012eb
|
055 |
1 |
0 |
|a HD9665.5
|b A24 2012
|
055 |
1 |
0 |
|a HD9665 .5
|b A33 2012
|
060 |
|
4 |
|a 2012 H-513
|
060 |
|
4 |
|a QV 21
|
072 |
|
7 |
|a BUS
|x 008000
|2 bisacsh
|
082 |
0 |
4 |
|a 174.2/951
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Access to medicines as a human right :
|b implications for pharmaceutical industry responsibility /
|c edited by Lisa Forman and Jillian Clare Kohler.
|
264 |
|
1 |
|a Toronto :
|b University of Toronto Press,
|c [2012]
|
264 |
|
4 |
|c ©2012
|
300 |
|
|
|a 1 online resource (vi, 214 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
0 |
|g Introduction :
|t access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? /
|r Lisa Forman and Jillian Clare Kohler --
|t Human rights responsibilities of pharmaceutical companies in relation to access to medicines /
|t Rajat Khosla and Paul Hunt --
|t Improving access to essential medicines : international law and normative change /
|r Asher Alkoby --
|t Corporate social responsibility and the right to essential medicines /
|r Patricia Illingworth --
|t Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility /
|r Matthew Lee and Jillian Clare Kohler --
|t Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? /
|r Joel Lexchin --
|t Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform /
|r Richard Eilliott --
|t Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa /
|r Judith King and Stephanie Nixon --
|g Annex :
|t human rights guidelines for pharmaceutical companies in relation to access to medicines.
|
520 |
|
|
|a "According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health?
|
520 |
|
|
|a This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Pharmaceutical industry
|x Moral and ethical aspects.
|
650 |
|
0 |
|a Pharmaceutical ethics.
|
650 |
|
0 |
|a Human rights
|x Health aspects.
|
650 |
|
0 |
|a Social responsibility of business.
|
650 |
|
0 |
|a Human rights.
|
650 |
1 |
2 |
|a Drug Industry
|x ethics
|
650 |
2 |
2 |
|a Health Services Accessibility
|x ethics
|
650 |
2 |
2 |
|a Human Rights
|
650 |
2 |
2 |
|a Social Responsibility
|
650 |
|
2 |
|a Ethics, Pharmacy
|
650 |
|
6 |
|a Industrie pharmaceutique
|x Aspect moral.
|
650 |
|
6 |
|a Pharmaciens
|x Déontologie.
|
650 |
|
6 |
|a Droits de l'homme (Droit international)
|x Aspect sanitaire.
|
650 |
|
6 |
|a Entreprises
|x Responsabilité sociale.
|
650 |
|
6 |
|a Droits de l'homme (Droit international)
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Business Ethics.
|2 bisacsh
|
650 |
|
7 |
|a Human rights.
|2 fast
|0 (OCoLC)fst00963285
|
650 |
|
7 |
|a Human rights
|x Health aspects.
|2 fast
|0 (OCoLC)fst00963298
|
650 |
|
7 |
|a Pharmaceutical ethics.
|2 fast
|0 (OCoLC)fst01060127
|
650 |
|
7 |
|a Pharmaceutical industry
|x Moral and ethical aspects.
|2 fast
|0 (OCoLC)fst01060163
|
650 |
|
7 |
|a Social responsibility of business.
|2 fast
|0 (OCoLC)fst01122851
|
700 |
1 |
|
|a Forman, Lisa,
|d 1970-
|
700 |
1 |
|
|a Kohler, Jillian Clare.
|
776 |
0 |
8 |
|i Print version:
|t Access to medicines as a human right
|z 9781442643970
|w (DLC) 2012406607
|w (OCoLC)791161904
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=682866
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4672976
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 682866
|
994 |
|
|
|a 92
|b IZTAP
|